Biden administration chooses first 10 drugs for Medicare price negotiations

By: - August 29, 2023 6:14 pm

(Photo by Angela Breck for Maryland Matters)

We Work for Health, an advocacy and communications initiative backed by the Pharmaceutical Research and Manufacturers of America (PhRMA) that maintains a coalition in Virginia, issued a statement criticizing the list as an “overstep” and warning the drug pricing provisions of the Inflation Reduction Act would prevent pharmaceutical companies from being able to reinvest profits in research and development of new medicines.

“Today’s announcement lacks critical details for the American patients and workers who will be directly harmed by this flawed, short-sighted policy,” wrote We Work for Health Executive Dan Leonard. “While there has been so much attention placed on the list of drugs, the reality is that a growing list of areas of unmet patient need will face even greater hurdles as a result of the flawed policies and implementation of the IRA.”

Our stories may be republished online or in print under Creative Commons license CC BY-NC-ND 4.0. We ask that you edit only for style or to shorten, provide proper attribution and link to our web site. Please see our republishing guidelines for use of photos and graphics.

Ashley Murray
Ashley Murray

Ashley Murray covers the nation’s capital as a senior reporter for States Newsroom. Her coverage areas include domestic policy and appropriations.